Brian McMahon

Brian J. McMahon MD is a clinical Hepatologist and the Scientific Program and Director of the Liver Disease and Hepatitis Program at the Alaska Native Medical Center in Anchorage, Alaska, and guest researcher at the Arctic Investigations Program of the Centers for Disease Control in Anchorage. He is a Clinical Professor of Medicine at the University of Washington, Seattle, and Professor of Health Sciences at the WWAMI Medical School, University of Alaska, Anchorage. He is a Fellow in the American Association for the Study of Liver Diseases and a Master in the American College of Physicians.   

He directs a patient care program for over 1200 Alaska Natives with chronic hepatitis B and 2400 with chronic hepatitis C. He conducts research on long-term protection studies on hepatitis A and B vaccines as well as studies on the outcome and management of chronic hepatitis B and C and autoimmune liver diseases, Non-Alcoholic Fatty Liver Diseases and Hepatocellular Carcinoma.   

  He is the coauthor of the American Association for the Study of Liver Disease (AASLD) US Practice Guideline on Chronic Hepatitis B with 4 updates from 2001 to 2009, on the methodology committee for the 2018 AASLD Guidelines. He also was co-chair of the WHO hepatitis B Guidelines Committee in 2015.  

He was a member of the Institute of Medicine Committee that published recommendations for Hepatitis and Liver Cancer in 2010. He has 170 peer-reviewed original scientific articles and 60 book chapters/review articles/editorials.